معرفی
Steven Nichtberger is an Adjunct Professor at the Wharton School of the University of Pennsylvania and Professor of Practice in the Life Sciences & Management (LSM) program. As Course Director of the LSM Capstone, he leads initiatives focused on healthcare company formation, financing, and leadership. A serial entrepreneur with 25+ years in the healthcare industry, he served as founding CEO of Cabaletta Bio (Nasdaq: CABA) and Tengion, and currently manages GBF, LLC, providing advisory and investment services to healthcare companies and academic scientists.
- B.A. in Biology from University of Pennsylvania's College of Arts & Sciences
- B.S. in Economics from Wharton School
- M.D. from SUNY at Buffalo School of Medicine and Biosciences
- Completed internship, residency, and fellowship at Mount Sinai Medical Center
His research interests center on commercializing medical innovations, pharmaceutical marketing strategy, and healthcare entrepreneurship. He also explores novel regulatory approaches and manufacturing frameworks in regenerative medicine. While no recent publications are listed, his work focuses on healthcare leadership and translational medicine.
- National Ernst and Young Entrepreneur of the Year Award (2008)
- William Whitney Award for Distinguished Teaching (2015)
Dr. Nichtberger previously held senior roles at Merck, including global marketing leadership and P&L responsibility for a $3.5 billion cardiovascular portfolio. He serves on multiple boards including Main Line Health and BioAdvance Greenhouse Fund, and advises the Israel Biotech Fund. His career bridges academia, biotech entrepreneurship, and pharmaceutical industry leadership.
